LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Search

Medpace Holdings Inc

Suletud

SektorTervishoid

433.28 1.17

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

430.85

Max

433.28

Põhinäitajad

By Trading Economics

Sissetulek

-11M

124M

Müük

-1.8M

707M

P/E

Sektori keskmine

26.739

49.701

Aktsiakasum

4.28

Kasumimarginaal

17.53

Töötajad

6,300

EBITDA

-16M

148M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+3.4% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

20. juuli 2026

Turustatistika

By TradingEconomics

Turukapital

-3B

12B

Eelmine avamishind

432.11

Eelmine sulgemishind

433.28

Uudiste sentiment

By Acuity

76%

24%

314 / 345 Pingereas Healthcare

Medpace Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. okt 2025, 15:15 UTC

Tulu

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Medpace Holdings Inc Prognoos

Hinnasiht

By TipRanks

3.4% tõus

12 kuu keskmine prognoos

Keskmine 447.5 USD  3.4%

Kõrge 495 USD

Madal 393 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Medpace Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

8 ratings

3

Osta

5

Hoia

0

Müü

Sentiment

By Acuity

314 / 345 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat